Harold Dremin

Représentations afin d'obtenir une subvention dans le cadre du programme Fonds Stratégique pour l'Innovation (FIS) de Innovation, Sciences, et Développement économique Canada (ISDE) ou d'éventuels autres organismes fédéraux, pour soutenir un projet d'agrandissement des infrastructures et d'acquisition d'équipements à la fine pointe et ainsi accroître la capacité de production et d'innovation de la société.

Seeking a grant under the Strategic Innovation Fund (SIF) program of Innovation, Science, and Economic Development Canada (ISED) or possibly from other federal agencies, to support a project for the expansion of our corporation's infrastructure and the acquisition of state-of-the-art equipment, thereby increasing the company's production and innovation capacity.

Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape. Innovation, Science and Economic Development (ISED)'s Health Emergency Readiness program, insofar as it pertains to growth and development of the life sciences industry in Canada. Communication regarding free trade agreements as they relate to the biopharmaceutical industry. The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors. Public Health Agency of Canada, regarding the federal response to the hepatitis C virus. Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada. Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages. Communications with Heath Canada regarding modernization of the medical devices regulatory framework. Communications with Health Canada regarding the evolution of the regulatory framework to address advanced therapeutic products. Communications with Health Canada regarding the application of its nitrosamine guidelines. Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials. Communications with Health Canada regarding guidelines for pediatric action plans. Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors. Communications regarding the design and implementation of the federal Drugs for Rare Diseases strategy. Communications regarding national pharmacare legislation, regulations, policies or programs. Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime. Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices. Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.

Discussing the development and implementation of measures to eliminate forced labour in supply chains. Discussing aerospace industry skilled labour requirements, including government immigration and employment support programs. Strategic Response Fund (SRF) – this program administered by ISED Canada co-invests with Canadian aerospace companies in funding their Research & Development (R&D) projects. AIAC advocates to ensure that the program’s mandate, funding level, and investment terms and conditions align to the R&D financing needs of Canadian aerospace companies and that they are equivalent to what other countries provide their aerospace companies. Strategic Response Fund (SRF) - proposal to support the development of an ecosystem in Canada by providing an environment for the pursuit of collaborative projects. Industrial and Technological Benefits (ITB) Policy – AIAC advocates to the government for a policy framework and eligibility rules that ensure high quality industrial benefits are placed into Canada by the primes. Discussing regional development in the province of British Columbia. Discussing the aerospace industry perspective on international trade negotiations and agreements to ensure their effectiveness. Discussing Canadian export controls and trade measures, including the Canada-United States-Mexico Agreement, to provide the industry’s perspective and ensure their effectiveness. Discussing how Transport Canada can improve its resources and governance structure for civil aviation, including improvements to certification processes and alignment with bilateral partners. Communications regarding the implementation of the Defence Industrial Strategy, including related policies, programs, regulations and legislation which support production capacity of the aerospace industry in Canada, increase supports for export opportunities and development of international markets. Ensuring the Defence Industrial Strategy implementation, including related policies, programs, regulations and legislation supports the growth of the aerospace industry in Canada. Advocate on current or future environmental, legislation, policy or regulations of potential impact. The Aeronautics Act and Canadian Aviation Regulations (CARs) - AIAC advocates for internationally harmonized implementation of regulations to get the highest practical level of safety and to keep Canadian industry economically competitive. Taxation Policy – AIAC advocates for a taxation policy regime that strengthens Canada as a place for new aerospace investment and for growing existing aerospace businesses. e.g. lowering of corporate taxation rates, allowing for greater and accelerated write-up of the purchase of new capital and equipment. Scientific Research & Experimental Development (SRED) Tax Credit – this program administered by Revenue Canada provides a tax credit to companies in proportion to their investments in Research & Development. AIAC advocates for eligibility rules and terms and conditions that meet the needs of Canadian aerospace companies regardless of their public or private ownership. Safety Management System (SMS) - The development of an internationally-recognized SMS Standard consistent with Annex 19. Obtain support from relevant government departments in dealing with the European Union Emissions Trading Scheme to ensure fairness to Canadian companies. Export Financing – Export Development Canada provides financing assistance to foreign buyers of Canadian products and systems. AIAC advocates for adequate financing support of aerospace exports and that the program's terms and conditions are aligned to market circumstances as well as keeping Canada's industry competitive internationally. Enhancement and growth of the Canadian Aviation Maintenance Council to cover all aviation human resource issues with particular focus on aerospace manufacturing, human resource issues; to include possible funding and activities Employment Insurance Policy – administered by Emp

Communications about the federal investment tax credits under the Income Tax Act for carbon capture, utilization and storage (CCUS) projects and initiatives (CCUS ITC). Communicate with government officials about funding for Carbon Dioxide Removal technologies (CDR) and in particular Direct Air Capture (DAC) technology through existing and emerging funding programs and mechanisms, including through CCUS (carbon capture utilization and storage) programs and initiatives. Advocate for competitive policies and programs that incentivize carbon dioxide removal (CDR) in general, and direct air capture (DAC) specifically in Canada.

C-64, An act respecting pharmacare - discussions around the structuring and implementation of a national pharmacare program. The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry Pharmaceutical pricing policy arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines. Patented Medicines Pricing Review Board (PMPRB) – regulations that can impact the Canadian pharmaceutical industry. Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry. Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention. Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly Canada's business Free trade treaty agreement as it relates to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to Columbia, India, and the European Union Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food and Drug Act.

Provide an overview of uranium exploration projects and the SABRE mining method. Exemptions to Canada's Non-Resident Ownership Policy in the Uranium Mining Sector (NROP), with regard to the minimum level of resident ownership in individual mining properties.

Input on tax policy as it relates to mining in Canada, innovation in mining, such as Scientific Research & Economic Development Tax Credits, and other tax policy matters impacting the mining industry. Input on red tape reduction items, such as CFIA bulk labelling requirements, and environmental or regulatory permitting requirements for mining and related supply chain infrastructure. Input on transportation infrastructure and improvements, and trade-enabling infrastructure to the benefit of Canadian exporters. Input on policy and recommendations related to mining, critical minerals, and natural resources, including the Canadian Minerals and Metals Plan. Input on economic policy and growth for Canada and Canadian exports Input on climate change and green house gas emissions reduction policy, including the Greenhouse Gas Pollution Pricing Act, Output-Based Pricing System. Input on Clean Fuel Standard regulations under the Canadian Environmental Protection Act, 1999. Input on Clean Electricity Regulations